Influence of Latent Miofascial Trigger Points in the Vertical Jump in Female Voleyball Players (LMTP_Volley)

To evaluate the effects of dry needling of latent myofascial trigger points on vertical jump height in female volleyball players

Study Overview

• Status: Not yet recruiting
• Conditions: Sports Physical Therapy
• Intervention / Treatment: Device: Dry Needling plus normal volleyball training; Other: Control Group

Detailed Description

Evaluate a sample of female volleyball players after using dry needling on latent myofascial trigger points and verify if it would have an improvement of the vertical jump

• Study Type: Interventional
• Enrollment (Anticipated): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Toledo, Spain, 45007
    • Alberto Sánchez Sierra

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Healthy female volleyball players
• No Lower limbs injuries in the last 6 months
• Presence of latent trigger points in gastrocnemius
• Familiar with performing CMJ test

Exclusion Criteria:

• Active trigger points in the lower limbs
• Any contraindication of usind dry needling
• Any pathology that prevented the performance of CMJ test

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Needly Group; Once the trigger point has been identified, we will use the Hong tecnique looking for a local spasm response	Device: Dry Needling plus normal volleyball training; Once the trigger point has been identified, we will use the Hong tecnique looking for a local spasm response
Active Comparator: Control Group; Normal volleyball training	Other: Control Group; Normal volleyball training

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	pre-intervention
Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	Immediately post-intervention
Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	72 hours post-intervention
Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	one week post-intervention

Collaborators and Investigators

• Sponsor: University of Castilla-La Mancha

Study record dates

Study Major Dates

• Study Start (Anticipated): October 15, 2021
• Primary Completion (Anticipated): January 15, 2022
• Study Completion (Anticipated): January 15, 2022

Study Registration Dates

• First Submitted: September 16, 2021
• First Submitted That Met QC Criteria: September 16, 2021
• First Posted (Actual): September 28, 2021

Study Record Updates

• Last Update Posted (Actual): September 28, 2021
• Last Update Submitted That Met QC Criteria: September 16, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: Sánchez-Sierra1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No